FDA Updates Meaning of ‘Healthy’ on Food Labels
THURSDAY, Dec. 19, 2024 (HeathDay News) -- The U.S. Food and Drug Administration wants to redefine the meaning of healthy food, issuing a new rule Thursday that changes the way food companies can claim their products are indeed nutritious.What foods will qualify for...
FDA Expands Approval of Vtama to Include Atopic Dermatitis
THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.The...
Cloudy Effluent Has High Predictive Value in Peritoneal Dialysis-Associated Peritonitis
Research shows the presence of cloudy effluent in peritoneal dialysis-associated peritonitis is highly predictive of vancomycin-sensitive infections.
Dr. Luis Sumoza on Guiding Patients & Care Teams in CLL
Luis Sumoza, MD, highlights the need to explain the disease, its consequences, and treatment side effects to patients, highlighting effective communication with primary care providers is crucial to ensure coordinated care.
Addressing Clinician-Reported Barriers Improves Confidence in PrEP Prescribing
Clinician-reported barriers to PrEP prescribing include finances, perceptions about HIV risk, lack of training, and the amount of time required for PrEP care.
Noninferiority of Reduced-Dose Anticoagulants Unproven for Recurrent VTE
Reduced-dose anticoagulants for extended VTE treatment were associated with more recurrent events but less bleeding, according to recent findings.
Dr. Justin Balko on Challenges & Emerging Biomarkers in Breast Cancer
Justin Balko, PharmD, PhD, reviews his session from SABCS 2024 where he discussed the challenges and advancements in immunotherapy for early-stage triple-negative breast cancer (TNBC). Additionally, he discusses the importance of identifying predictive biomarkers to optimize treatment and improve patient quality of life.
Evaluating Auto-HCT for MCL With Undetectable Residual Disease
Auto-HCT showed no survival benefit over maintenance therapy alone in patients with mantle cell lymphoma with undetectable MRD in first complete remission.
Does Emphysema Impact Treatment Response in Severe Asthma?
Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study.
Predicting Early Versus Late Response to Treatment in SEA
Early improvement was linked to lower baseline FEV1 and higher eosinophils in severe eosinophilic asthma, while late improvement was linked to high ACT scores.
FDA Updates Meaning of ‘Healthy’ on Food Labels
THURSDAY, Dec. 19, 2024 (HeathDay News) -- The U.S. Food and Drug Administration wants to redefine the meaning of healthy food, issuing a new rule Thursday that changes the way food companies can claim their products are indeed nutritious.What foods will qualify for...
FDA Expands Approval of Vtama to Include Atopic Dermatitis
THURSDAY, Dec. 19, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.The...
Cloudy Effluent Has High Predictive Value in Peritoneal Dialysis-Associated Peritonitis
Research shows the presence of cloudy effluent in peritoneal dialysis-associated peritonitis is highly predictive of vancomycin-sensitive infections.
Dr. Luis Sumoza on Guiding Patients & Care Teams in CLL
Luis Sumoza, MD, highlights the need to explain the disease, its consequences, and treatment side effects to patients, highlighting effective communication with primary care providers is crucial to ensure coordinated care.
Addressing Clinician-Reported Barriers Improves Confidence in PrEP Prescribing
Clinician-reported barriers to PrEP prescribing include finances, perceptions about HIV risk, lack of training, and the amount of time required for PrEP care.
Noninferiority of Reduced-Dose Anticoagulants Unproven for Recurrent VTE
Reduced-dose anticoagulants for extended VTE treatment were associated with more recurrent events but less bleeding, according to recent findings.
Dr. Justin Balko on Challenges & Emerging Biomarkers in Breast Cancer
Justin Balko, PharmD, PhD, reviews his session from SABCS 2024 where he discussed the challenges and advancements in immunotherapy for early-stage triple-negative breast cancer (TNBC). Additionally, he discusses the importance of identifying predictive biomarkers to optimize treatment and improve patient quality of life.
Evaluating Auto-HCT for MCL With Undetectable Residual Disease
Auto-HCT showed no survival benefit over maintenance therapy alone in patients with mantle cell lymphoma with undetectable MRD in first complete remission.
Does Emphysema Impact Treatment Response in Severe Asthma?
Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study.
Predicting Early Versus Late Response to Treatment in SEA
Early improvement was linked to lower baseline FEV1 and higher eosinophils in severe eosinophilic asthma, while late improvement was linked to high ACT scores.
